TrueBlue Inc (TBI) Stock Analysis
Verdict: WATCH (do not buy)
Insider-led recovery meets structural margin pressure; the model sees the stock as overextended relative to its $5.50 fair value ceiling.
Investment score: 44/100
Analysis as of
Is TrueBlue Inc stock worth reviewing? The TradeMates thesis
TrueBlue is a highly cyclical, low-margin staffing firm currently enduring a difficult turnaround. While technical momentum is strong, the fundamentals (negative FCF, shrinking cash) and valuation (trading 20%+ above analyst targets) suggest the recent rally is exhausted.
7-factor investment score
- Valuation: 40/100 (weight 20%)
- Financial Health: 25/100 (weight 15%)
- Technical Momentum: 75/100 (weight 15%)
- Earnings Quality: 35/100 (weight 15%)
- Insider Sentiment: 70/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 40/100 (weight 15%)
TrueBlue Inc opportunities and risks
What speaks for TBI
- High operating leverage in recovery
What speaks against TBI
- Severe Cash Burn and Liquidity Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| TBI | n/a | 0.1x | n/a | 21.2% | -3.2% | -29.7% |
| BBSI | 21.1x | 0.7x | 9.4x | 20.7% | 3.2% | 2.2% |
| KELYA | n/a | 0.1x | n/a | 19.5% | -6.4% | 16.1% |
| ALIT | n/a | 0.2x | n/a | 20.2% | -137.5% | 72.3% |
| YUMM | n/a | 0.0x | 0.0x | 0.0% | 0.0% | -0.0% |
| ASUR | n/a | 1.7x | 11.9x | 67.9% | -6.8% | 3.9% |
| Peer median | n/a | 0.2x | 0.0x | 20.2% | -6.4% | 3.9% |
Frequently asked questions about TrueBlue Inc (TBI)
Is TBI stock a good investment?
The TradeMates model rates TrueBlue Inc as WATCH (do not buy) with an investment score of 44/100. TrueBlue is a highly cyclical, low-margin staffing firm currently enduring a difficult turnaround. While technical momentum is strong, the fundamentals (negative FCF, shrinking cash) and valuation (trading 20%+ above analyst targets) suggest the recent rally is exhausted. This is algorithmic model output, not personal investment advice.
Is TBI stock a buy?
The TradeMates model verdict for TBI is WATCH (do not buy) with an investment score of 44/100. Treat this as a model signal to review, not a personal buy recommendation.